Gilead gets green light for inhaled remdesivir study
After receiving FDA approval, the pharmaceutical company has announced plans to launch a Phase I trial for an inhaled version of the COVID-19 treatment.
Archives for June 23, 2020
Lonza launches double-blinded capsules for trials
The company’s Capsugel DBcaps double-blinded capsules are designed to over-encapsulate drugs during clinical phases opaquely and securely.
ERT acquires wearable technology specialist
With its purchase of ADPM Wearable Technologies, the technology provider is looking to provide more cost-effective, efficient data gathering solutions.